![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 8, 3472-3476, 03, 1987
W Rouslin
In the present study we examined factors affecting the reversal of the
ischemia-induced protonic inhibition of the mitochondrial ATPase described
earlier (Rouslin, W. (1983) J. Biol. Chem. 258, 9657-9661). It was found
that ATPase reactivation and accompanying inhibitor protein release during
the re-energization of intact mitochondria isolated from 20-min ischemic
canine heart muscle could be blocked completely by either carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP) or nigericin but was unaffected by
valinomycin at 35 mM K+. At higher K+ concentrations, valinomycin also
blocked ATPase reactivation but not quite as completely as did nigericin.
These observations suggest that ATPase reactivation and inhibitor protein
release are particularly dependent upon either the trans-inner membrane pH
gradient (delta pH) or possibly upon matrix pH per se and slightly less
dependent upon membrane potential (delta psi) in intact cardiac muscle
mitochondria. The addition of FCCP at the end of the re-energization
incubations limited partially the extent of both ATPase reactivation and
inhibitor protein release. This latter effect appears to have been mediated
by a partial reassociation of the inhibitor protein with the enzyme, and it
was accentuated (when FCCP was added at the end of the incubations) or
mimicked (when FCCP was absent) by lowering the pH of the re-energization
medium. A close examination of the first 10 min of the time course of
enzyme activation and of inhibitor protein release revealed that while the
former process was essentially finished in 1 min or less, the latter
required approximately 10 min for completion. This observation led to the
proposal of a two-site model of enzyme- inhibitor interaction which is
discussed.
Factors affecting the reactivation of the oligomycin-sensitive adenosine 5'-triphosphatase and the release of ATPase inhibitor protein during the re-energization of intact mitochondria from ischemic cardiac muscle
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Corvest, C. Sigalat, R. Venard, P. Falson, D. M. Mueller, and F. Haraux The Binding Mechanism of the Yeast F1-ATPase Inhibitory Peptide: ROLE OF CATALYTIC INTERMEDIATES AND ENZYME TURNOVER J. Biol. Chem., March 18, 2005; 280(11): 9927 - 9936. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Burwick, M. L. Wahl, J. Fang, Z. Zhong, T. L. Moser, B. Li, R. A. Capaldi, D. J. Kenan, and S. V. Pizzo An Inhibitor of the F1 Subunit of ATP Synthase (IF1) Modulates the Activity of Angiostatin on the Endothelial Cell Surface J. Biol. Chem., January 21, 2005; 280(3): 1740 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rouslin and C. W. Broge IF1 Function in Situ in Uncoupler-challenged Ischemic Rabbit, Rat, and Pigeon Hearts J. Biol. Chem., September 27, 1996; 271(39): 23638 - 23641. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |